Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2026 08:00 ET | Source: MannKind

MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Q4 2025 revenues of $112M, +46% vs. Q4 2024 Furoscix® Q4 2025 net sales of $23M, +91% vs. Q4 2024 Afrezza® Q4 2025 net sales of $23M, +25% vs. Q4 2024 2025 full year revenues of $349M, +22% vs....
February 19, 2026 09:00 ET | Source: MannKind

MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced Chief Executive Officer Michael Castagna, PharmD is...